IFC proposes $50m investment in Indian pharma contract manufacturer Hikal

IFC proposes $50m investment in Indian pharma contract manufacturer Hikal

International Finance Corporation (IFC), a member of the World Bank Group, is proposing a $50-million investment in Hikal Ltd, a contract pharmaceutical manufacturing company in India, according to a disclosure.

The proposed investment will partly finance Hikal’s multi-year capital expenditure plan across its facilities for product and capacity expansion, IFC said.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter